LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Focus 76Bio is dedicated to developing next-generation targeted protein degraders for treating life-threatening diseases, highlighting its commitment to cutting-edge biotechnology solutions that appeal to clinical research and pharmaceutical partners.

Startup Potential With a small team of 2 to 10 employees and recent funding of 10 million dollars, 76Bio presents an opportunity for strategic collaborations, partnership development, or investment to support its growth trajectory in the competitive biotech space.

Technology Stack Utilizing a modern technological infrastructure including MySQL, open-source frameworks, and cloud services like Amazon ALB, 76Bio indicates readiness for scalable data management and digital engagement strategies, suitable for partners seeking innovative tech integration.

Market Positioning Operating within the highly competitive biotech research industry alongside giants like Roche and Pfizer, 76Bio's focus on targeted therapies could fit well with companies exploring novel approaches in precision medicine and drug development.

Financial Opportunity With a revenue estimate between 1 million and 10 million dollars and a substantial funding round, there is potential for business expansion, licensing agreements, or joint ventures aimed at accelerating therapeutic innovation and commercialization.

76Bio, Inc. Tech Stack

76Bio, Inc. uses 8 technology products and services including MySQL, jQuery, Amazon ALB, and more. Explore 76Bio, Inc.'s tech stack below.

  • MySQL
    Database
  • jQuery
    Javascript Libraries
  • Amazon ALB
    Load Balancers
  • Trustpilot
    Online Review Management
  • Elementor
    Page Builders
  • PHP
    Programming Languages
  • OpenResty
    Web Servers
  • Apache
    Web Servers

Media & News

76Bio, Inc.'s Email Address Formats

76Bio, Inc. uses at least 1 format(s):
76Bio, Inc. Email FormatsExamplePercentage
FL@76bio.comJD@76bio.com
87%
F.Last@76bio.comJ.Doe@76bio.com
13%

Frequently Asked Questions

Where is 76Bio, Inc.'s headquarters located?

Minus sign iconPlus sign icon76Bio, Inc.'s main headquarters is located at Boston, Massachusetts 02135 United States. The company has employees across 2 continents, including North AmericaAsia.

What is 76Bio, Inc.'s official website and social media links?

Minus sign iconPlus sign icon76Bio, Inc.'s official website is 76bio.com and has social profiles on LinkedInCrunchbase.

What is 76Bio, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon76Bio, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does 76Bio, Inc. have currently?

Minus sign iconPlus sign iconAs of May 2026, 76Bio, Inc. has approximately 3 employees across 2 continents, including North AmericaAsia. Key team members include Scientific Founder: A. K.. Explore 76Bio, Inc.'s employee directory with LeadIQ.

What industry does 76Bio, Inc. belong to?

Minus sign iconPlus sign icon76Bio, Inc. operates in the Biotechnology Research industry.

What technology does 76Bio, Inc. use?

Minus sign iconPlus sign icon76Bio, Inc.'s tech stack includes MySQLjQueryAmazon ALBTrustpilotElementorPHPOpenRestyApache.

What is 76Bio, Inc.'s email format?

Minus sign iconPlus sign icon76Bio, Inc.'s email format typically follows the pattern of FL@76bio.com. Find more 76Bio, Inc. email formats with LeadIQ.

How much funding has 76Bio, Inc. raised to date?

Minus sign iconPlus sign icon As of May 2026, 76Bio, Inc. has raised $10M in funding. The last funding round occurred on Jan 07, 2022 for $10M.

When was 76Bio, Inc. founded?

Minus sign iconPlus sign icon76Bio, Inc. was founded in 2020.

76Bio, Inc.

Biotechnology ResearchMassachusetts, United States2-10 Employees

76Bio, Inc. is a biotechnology research company based in Boston, Massachusetts. It concentrates on developing therapies for life-threatening diseases by pursuing a next-generation approach to protein degradation, a strategy aimed at removing disease-causing proteins from the body. The company operates with a small team, reflecting its early-stage, research-focused status. Its overarching aim is to deliver therapies that could transform outcomes for patients facing severe illnesses.

Its focus places it within the biotechnology research sector that seeks innovative therapeutic modalities to help patients with life-threatening conditions. By pursuing novel protein-degradation interventions, 76Bio aims to expand treatment options and advance the clinical potential of its approach.

Section iconCompany Overview

Headquarters
Boston, Massachusetts 02135 United States
Website
76bio.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $10M

    76Bio, Inc. has raised a total of $10M of funding over 1 rounds. Their latest funding round was raised on Jan 07, 2022 in the amount of $10M.

  • $1M$10M

    76Bio, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $10M

    76Bio, Inc. has raised a total of $10M of funding over 1 rounds. Their latest funding round was raised on Jan 07, 2022 in the amount of $10M.

  • $1M$10M

    76Bio, Inc.'s revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    A. K.
    Scientific Founder
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.